Literature DB >> 11421367

Molecular epidemiology of malaria in Yaounde, Cameroon. VII. Analysis of recrudescence and reinfection in patients with uncomplicated falciparum malaria.

L K Basco1, P Ringwald.   

Abstract

In an endemic area where malaria transmission is intense and continuous, reappearance of asexual parasites may be ascribed to either recrudescence or reinfection. To distinguish between recrudescence and reinfection after oral treatment with chloroquine, amodiaquine, pyronaridine, sulfadoxine-pyrimethamine, halofantrine, or artesunate, three polymorphic markers (circumsporozoite protein, merozoite surface antigens 1 and 2) from pre-treatment and post-treatment samples were amplified by the polymerase chain reaction, and the in vitro response to chloroquine was determined for comparison. Of 52 paired samples, 22 (42%) were reinfections. Recrudescence occurred more frequently on or before Day 14 (22 of 30 cases, 73%). Except for one case, all reinfections were observed beyond Day 14. The phenotype determination was not sufficiently precise to distinguish between recrudescence and reinfection. Our results suggest that beyond Day 14 (and until Day 42), recrudescence and reinfection cannot be distinguished at our study site unless molecular techniques are used and that some results derived from the polymerase chain reaction need to be compared with the microscopic examination of thick blood smear to exclude gametocyte carriers without asexual parasites after treatment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11421367

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  5 in total

Review 1.  Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria.

Authors:  Richard T Eastman; David A Fidock
Journal:  Nat Rev Microbiol       Date:  2009-11-02       Impact factor: 60.633

2.  Methodological issues in the assessment of antimalarial drug treatment: analysis of 13 studies in eight African countries from 2001 to 2004.

Authors:  Jean-Paul Guthmann; Loretxu Pinoges; Francesco Checchi; Simon Cousens; Suna Balkan; Michel van Herp; Dominique Legros; Piero Olliaro
Journal:  Antimicrob Agents Chemother       Date:  2006-09-05       Impact factor: 5.191

3.  Genetic diversity of Plasmodium falciparum field isolates from south western Nigeria.

Authors:  G I Olasehinde; C S Yah; R Singh; O Olusola Ojuronbge; A A Ajayi; N Valecha; A O Abolaji; A O Adeyeba
Journal:  Afr Health Sci       Date:  2012-09       Impact factor: 0.927

4.  Review of pyronaridine anti-malarial properties and product characteristics.

Authors:  Simon L Croft; Stephan Duparc; Sarah J Arbe-Barnes; J Carl Craft; Chang-Sik Shin; Lawrence Fleckenstein; Isabelle Borghini-Fuhrer; Han-Jong Rim
Journal:  Malar J       Date:  2012-08-09       Impact factor: 2.979

5.  A comprehensive analysis of drug resistance molecular markers and Plasmodium falciparum genetic diversity in two malaria endemic sites in Mali.

Authors:  Seidina A S Diakité; Karim Traoré; Ibrahim Sanogo; Taane G Clark; Susana Campino; Modibo Sangaré; Djeneba Dabitao; Antoine Dara; Drissa S Konaté; Fousseyni Doucouré; Amadou Cissé; Bourama Keita; Mory Doumbouya; Merepen A Guindo; Mahamoudou B Toure; Nafomon Sogoba; Seydou Doumbia; Gordon A Awandare; Mahamadou Diakité
Journal:  Malar J       Date:  2019-11-12       Impact factor: 2.979

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.